Shockwave Medical is a pioneering medical device company focused on developing and commercializing innovative intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with cardiovascular disease. Their proprietary IVL system utilizes sonic pressure waves to safely and effectively modify calcified lesions in coronary and peripheral arteries, thereby enabling optimal stent deployment and improving patient outcomes. The company aims to establish a new standard of care for treating severely calcified arterial disease. In April 2024, Johnson & Johnson announced a definitive agreement to acquire Shockwave Medical.
The headquarters serves as the primary center for research and development, corporate strategy, global marketing, engineering, and administrative operations.
The facility is likely a modern office and lab space designed to foster innovation, featuring advanced research and development laboratories and collaborative workspaces tailored for medical device development.
The work culture is typically characterized by a fast-paced, innovative, and collaborative environment, driven by a mission to improve patient lives through groundbreaking medical technology. Employees often highlight the impact of their work and the dynamic nature of the medtech industry.
Its Silicon Valley location provides access to a rich talent pool, cutting-edge technological advancements, and a vibrant ecosystem of suppliers, partners, and research institutions critical for a leading medical device company.
Shockwave Medical has established a significant global presence with direct sales operations and distribution networks across North America, Europe, Japan, and other key international markets. This global footprint supports worldwide clinical research, regulatory approvals, product commercialization, physician training programs, and ongoing customer support for its intravascular lithotripsy portfolio.
5403 Betsy Ross Drive
Santa Clara
California
USA
Address: Ammerthalstraße 26, 85551 Kirchheim bei München, Germany
To drive market penetration, provide localized customer service and training, and manage regulatory compliance for European markets.
Address: Level 20, Marunouchi Trust Tower Main, 1-8-3 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
To expand the use of IVL technology in Japan, navigate local regulatory landscapes, and build strong relationships with Japanese healthcare professionals and institutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Shockwave Medical' leadership includes:
Shockwave Medical has been backed by several prominent investors over the years, including:
The most significant news impacting the executive team is the pending acquisition by Johnson & Johnson, announced in April 2024. Details on the future leadership structure post-acquisition are typically determined during and after the integration process. In the 12 months preceding this announcement, Shockwave Medical's core executive team remained largely stable with no major publicly announced C-suite hires or departures.
Discover the tools Shockwave Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Shockwave Medical commonly utilizes the email format consisting of the first initial directly followed by the last name. This is a prevalent format among many corporations.
flast@shockwavemedical.com
Format
dgodshall@shockwavemedical.com
Example
80%
Success rate
Johnson & Johnson • April 5, 2024
Johnson & Johnson announced it has entered into a definitive agreement to acquire Shockwave Medical, Inc. for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion. The acquisition is aimed at expanding J&J MedTech's position in cardiovascular intervention....more
Shockwave Medical Investor Relations • February 20, 2024
Shockwave Medical reported record revenue of $203.0 million for the fourth quarter of 2023, a 41% increase from the same period in 2022, and full-year 2023 revenue of $730.2 million, a 49% increase from full-year 2022. Growth was attributed to continued adoption of IVL technology....more
Shockwave Medical Investor Relations • November 7, 2023
Shockwave Medical announced financial results for the third quarter ended September 30, 2023, reporting revenue of $186.0 million, a 42% increase from the third quarter of 2022, driven by strong performance across its coronary and peripheral product lines....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Shockwave Medical, are just a search away.